Binding capacity of auryxia
WebJan 15, 2015 · Auryxia belongs to a group of drugs called ferric iron-based phosphate binders. These work by binding to phosphate in the body to pass it through the digestive system and eliminate the phosphate through the stool. In addition, Auryxia can help replenish iron in the body necessary to make red blood cells. WebThe NDC Code 59922-631-01 is assigned to a package of 200 tablet, film coated in 1 bottle of Auryxia, a human prescription drug labeled by Akebia Therapeutics, Inc.. The product's dosage form is tablet, film coated and is administered via oral form. The following table has all the important details about this NDC code, including the 11-Digit ...
Binding capacity of auryxia
Did you know?
WebPhosphate-binding compounds were introduced in the 1970s for the treatment of hyperphosphatemia in pa- tientsondialysisafteritwasobservedthatoraladministrationofaluminumhydroxideasanantacidalsoreducedserumPO WebFind information about common, infrequent and rare side effects of Auryxia
WebDec 12, 2024 · Auryxia (ferric citrate), a phosphate binder and iron replacement product, is known chemically as iron (+3), x (1, 2, 3-propanetricarboxylic acid, 2 hydroxy-), y (H 2 O) …
WebAURYXIA contains iron. Keep it away from children to prevent an accidental ingestion of iron and potentially fatal poisoning. Call a poison control center or your healthcare provider if a child swallows AURYXIA AURYXIA can increase iron levels in your blood. Iron absorbed from AURYXIA may also increase iron in your body. WebAuryxia ® (ferric citrate; Keryx Biopharmaceuticals, Inc., Boston, MA, USA) is an iron-based compound with distinctive chemical characteristics and a mechanism of action that render it dually effective as a therapy in patients with CKD; it has been approved as a phosphate binder for the control of serum phosphate levels in adult CKD patients …
WebJul 19, 2024 · Auryxia (ferric citrate) is a phosphate binder used for the control of serum phosphorus levels in patients with chronic kidney disease on dialysis. What are side effects of Auryxia? Common side effects of …
WebAuryxia ® (ferric citrate; Keryx Biopharmaceuticals, Inc., Boston, MA, USA) is an iron-based compound with distinctive chemical characteristics and a mechanism of action that … katys church road muncy paWebJan 2, 2024 · National Center for Biotechnology Information katys cozy cabins number 4WebAuryxia® (ferric citrate; Keryx Biopharmaceuticals, Inc., Boston, MA, USA) is an iron-based compound with distinctive chemical characteristics and a mechanism of action that render it dually effective as a therapy in patients with CKD; it has been approved as a phosphate binder for the control of serum phosphate levels in adult CKD patients ... katys touch tilbury ontarioWebAuryxia (ferric citrate) only works when it's taken with meals. It binds to the phosphorus in your food, so if you take it on an empty stomach, there's no food for it to bind to. If you … katys personal touchWebFeb 19, 2015 · Auryxia will seek to take patients from Sanofi's ( SNY) Renvela, which is the most commonly prescribed phosphate binder for chronic CKD patients on dialysis, with estimated U.S. sales of over... katys own delivery llcWebJul 19, 2024 · Auryxia (ferric citrate) is a phosphate binder used for the control of serum phosphorus levels in patients with chronic kidney disease on dialysis. What Are Side Effects of Auryxia? Common side effects of Auryxia include: diarrhea, nausea, constipation, vomiting, cough, and dark stools (related to the iron content). katys fish and chips barnard castleWebFind information on Ferric Citrate (Auryxia) in Davis’s Drug Guide including dosage, side effects, interactions, nursing implications, mechanism of action, half life, administration, and more. Davis Drug Guide PDF. katytheater.org